Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes. Krayim B, Shalata W, Bar J, Moskovitz M, et al. Lung Cancer 2025;205:108598.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Krayim B, Shalata W, Bar J, Moskovitz M, et al. Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes. Lung Cancer 2025;205:108598.
PMID: 40482375